Lupin Limited has informed the Exchange regarding a press release dated May 26, 2023, titled "Lupin Announces Health Canada Approval of Tiotropium Bromide Inhalation Powder for Treatment of COPD".
Lupin Limited has informed the Exchange regarding a press release dated May 26, 2023, titled "Lupin Announces Health Canada Approval of Tiotropium Bromide Inhalation Powder for Treatment of COPD".